Interstitial pulmonary fibrosis is a lethal, chronic response to lung injury. Although numerous agents can elicit interstitial fibrosis in the lung, no eliciting factors can be identified in many cases. The biochemical mechanisms leading to diffuse interstitial pulmonary fibrosis are poorly characterized. Increasing evidence indicate that reactive oxygen species and proteases are involved in the pathogenesis of this disease. The antioxidant enzyme extracellular superoxide dismutase (EC-SOD) is highly expressed in the lung and is the major antioxidant enzyme in the extracellular matrix. EC-SOD has a heparin-binding domain that regulates its biodistribution in the extracellular matrix. This domain is sensitive to proteolysis, and proteolytic removal of the heparin-binding domain may be a primary mechanism to regulate EC-SOD levels in extracellular spaces. We found that this enzyme protects against pulmonary fibrosis and that its distribution is significantly changed as a result of proteolysis in a bleomycin model of pulmonary fibrosis. Latent metalloproteases, enzymes that degrade components of the extracellular matrix including collagen, can be activated by oxidants such as superoxide and have been implicated in the pathogenesis of pulmonary fibrosis. We have found that these proteases can also cut EC-SOD's heparin-binding domain. Thus, oxidants can increase the protease/antiprotease balance in the lung that can then lead to proteolytic clearance of EC-SOD from the lung resulting in an oxidant/antioxidant imbalance. This proposal will investigate the synergistic effects of oxidants and proteases in the pathogenesis of pulmonary fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063700-07
Application #
7226334
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Reynolds, Herbert Y
Project Start
1999-12-01
Project End
2010-04-30
Budget Start
2007-05-01
Budget End
2008-04-30
Support Year
7
Fiscal Year
2007
Total Cost
$300,737
Indirect Cost
Name
University of Pittsburgh
Department
Pathology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Manni, Michelle L; Epperly, Michael W; Han, Wei et al. (2012) Leukocyte-derived extracellular superoxide dismutase does not contribute to airspace EC-SOD after interstitial pulmonary injury. Am J Physiol Lung Cell Mol Physiol 302:L160-6
Manni, Michelle L; Czajka, Caitlin A; Oury, Tim D et al. (2011) Extracellular matrix powder protects against bleomycin-induced pulmonary fibrosis. Tissue Eng Part A 17:2795-804
Kliment, Corrine R; Oury, Tim D (2011) Extracellular superoxide dismutase protects cardiovascular syndecan-1 from oxidative shedding. Free Radic Biol Med 50:1075-80
Manni, Michelle L; Tomai, Lauren P; Norris, Callie A et al. (2011) Extracellular superoxide dismutase in macrophages augments bacterial killing by promoting phagocytosis. Am J Pathol 178:2752-9
Kliment, Corrine R; Englert, Judson M; Crum, Lauren P et al. (2011) A novel method for accurate collagen and biochemical assessment of pulmonary tissue utilizing one animal. Int J Clin Exp Pathol 4:349-55
Petersen, Steen V; Thogersen, Ida B; Valnickova, Zuzana et al. (2010) The concentration of extracellular superoxide dismutase in plasma is maintained by LRP-mediated endocytosis. Free Radic Biol Med 49:894-9
Ganguly, Koustav; Depner, Martin; Fattman, Cheryl et al. (2009) Superoxide dismutase 3, extracellular (SOD3) variants and lung function. Physiol Genomics 37:260-7
Kliment, Corrine R; Suliman, Hagir B; Tobolewski, Jacob M et al. (2009) Extracellular superoxide dismutase regulates cardiac function and fibrosis. J Mol Cell Cardiol 47:730-42
Kliment, Corrine R; Englert, Judson M; Gochuico, Bernadette R et al. (2009) Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis. J Biol Chem 284:3537-45
Englert, Judson M; Hanford, Lana E; Kaminski, Naftali et al. (2008) A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 172:583-91

Showing the most recent 10 out of 49 publications